Eli Lilly and Company

Industry

  • Digital Health
    • Disease Management
  • Pharmaceuticals

Other Names/Subsidiaries

  • Advanced Cardiovascular Systems
  • Akouos
  • Applied Molecular Evolution
  • Armo Biosciences
  • Avid Radiopharmaceuticals
  • Boehringer Ingelheim Vetmedica
  • Cardiac Pacemakers
  • ChemGen
  • Chorus Pharma
  • CoLucid Pharmaceuticals
  • Dermira
  • Devices for Vascular Intervention
  • DICE Therapeutics
  • Disarm Therapeutics
  • Emergence Therapeutics
  • Heart POINT Biopharma Group
  • Heart Rhythm Technologies
  • Hybritech
  • Morphic Holding
  • ICOS Corporation
  • Morphic Therapeutic
  • Novartis AH
  • Mablink Bioscience
  • Petra Pharma
  • Prevail Therapeutics
  • Protomer Technologies
  • Rhythm Technologies
  • Scorpion Therapeutics
  • Sigilon Therapeutics
  • Versanis BioTechnologies
See more in Biomedtracker

Latest on Eli Lilly and Company

Scrip

Lilly Looks For Muscle-Sparing Candidates In Pact With Juvena

 
• By Joseph Haas

Who: Eli Lilly/Juvena Therapeutics What: Juvena will use its AI platform JuvNET to identify stem cell-secreted protein drug candidates to help patients on obesity therapy maintain muscle mass and f

Scrip

Novo Nordisk Teams With Deep Apple On Non-Incretin Obesity Approach

 
• By Joseph Haas

In its sixth cardiometabolic disease deal of 2025, Novo Nordisk – reportedly concerned about its standing in the obesity and diabetes space versus its nearest rival, Eli Lilly – will turn to Deep Ap

Scrip

Titans Of Pharma: Lilly’s Ricks Tops Big Pharma Pay Chart

 
• By Eleanor Malone, Edwin Elmhirst, and Kosh Naran

Riding high on the wave of its dual GIP/GLP-1 agonist, tirzepatide, Eli Lilly awarded its CEO the highest total remuneration package of the top 12 big pharma companies in 2024. David Ricks’s total com

Scrip

Pharma’s Space Trails Entering Transformative Era - Keytruda’s Been There

 
• By Anju Ghangurde

Pharma appears to be at the dawn of a transformative era in space-based research. From leveraging microgravity effects to biomanufacturing in orbit for ultra-pure biologics, industry is exploring a ho